Showing 501-510 of 1539 results for "".
Clinical Conversations: The Data for JAK Inhibitors in AD
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-the-data-for-jak-inhibitors-in-ad/20105/JAK inhibitors represent a new therapeutic class for the treatment of atopic dermatitis. Find out what the data show about their efficacy and tolerability in a conversation between Brad Glick, DO and Raj Chovatiya, MD. Discover how these drugs can fit into the treatment plan and how these experts diGalderma, Allergan Rosacea News, Dupilumab Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-allergan-rosacea-news-dupilumab-data/18591/Galderma Laboratories launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33. The FDA has accepted Allergan's New Drug Application (NDA) filing for oxymetazoline cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema assoSave Big Bucks by Using Vendor-Sponsored Customer Loyalty Programs
https://practicaldermatology.com/topics/practice-management/save-big-bucks-by-using-vendor-sponsored-customer-loyalty-programs/21223/Vendors invest millions of dollars in sophisticated direct-to-consumer loyalty campaigns designed to drive traffic to the practices they serve. Smart practices use these programs to their advantage to reward, recruit, retain, and convert patients.Skin Coverage as a Medical Benefit
https://practicaldermatology.com/series/c-suite-chats/skin-coverage-as-a-medical-benefit/35559/Mike Jafar, Founder and CEO of Joya Health, talks about the importance of having skin coverage as a medical benefit, trends in dermatology, and the driver behind the rising rates of melanoma.Dermatology Innovations
https://practicaldermatology.com/topics/psoriasis/dermatology-innovations/20044/From topical therapies to JAK inhibitors, there are many new drugs available to treat a wide variety of dermatologic conditions. Neal Bhatia, MD reviews what's new for atopic dermatitis, alopecia areata, scabies, lice, onychomycosis, and more. Plus, he discusses the importance of new delivery systemWord of Mouth Advertising Done Right
https://practicaldermatology.com/topics/practice-management/word-of-mouth-advertising-done-right/19064/Tracy Drumm, Vice President of IF Marketing shares insider tips for effective word of mouth advertising for the cosmetic or aesthetic practice.Contact Dermatitis and Hair Care
https://practicaldermatology.com/topics/feature/contact-dermatitis-and-hair-care/29190/Hair care products can have a significant effect on the health of the skin, and contribute to other skin issues, including acne, dry scalp, and even hair shedding.Smoothing Out Our Understanding of Moisturizers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/smoothing-out-our-understanding-of-moisturizers/20688/New science and new approaches for dry skin.Pros and Cons of DTC Advertising
https://practicaldermatology.com/topics/practice-management/pros-and-cons-of-dtc-advertising/18569/Hilary Baldwin, MD and James Q. Del Rosso, DO sit down with Derm Insider Host Neal Bhatia, MD to weigh the pros and cons of direct-to-consumer advertising on patients. They agree that if done well and with a primary focus on disease state rather than a specific drug, these ads can encourage patientsInnovations in Cosmeceuticals
https://practicaldermatology.com/topics/general-topics/innovations-in-cosmeceuticals/18969/In this edition of DermTube Journal Club, Zoe Diana Draelos, MD speaks with host Joshua Zeichner, MD about the latest updates in the world of cosmeceuticals, particularly polymer technology, anti-aging genes, and glycan sugar.